Many receptors are known to be overexpressed in cancer cells, like folic acid receptor (FR) [12], transferrin receptor (TfR) [13], or epidermal growth factor receptor (EGFR) [14], which have been explored as docking sites for selective targeting of anticancer chemotherapeutics [15]. The gene discussed is EGFR; the disease is cancer.